Related Experiment Video
Updated: Apr 5, 2026

Composite Scaffolds of Interfacial Polyelectrolyte Fibers for Temporally Controlled Release of Biomolecules
Published on: August 19, 2015
Controlled release of bioactive PDGF-AA from a hydrogel/nanoparticle composite
Irja Elliott Donaghue1, Molly S Shoichet2
1Department of Chemical Engineering and Applied Chemistry, University of Toronto, Canada; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Canada.
Low molecular weight poly(ethylene glycol) (PEG) unexpectedly accelerated platelet-derived growth factor-AA (PDGF-AA) aggregation in nanoparticles, reducing its bioactivity. However, PDGF-AA released without PEG remained bioactive, demonstrating a novel delivery system for neural regeneration.
Area of Science:
- Biomaterials Science
- Neuroscience
- Drug Delivery Systems
Background:
- Polymeric nanoparticles are utilized for protein encapsulation, but excipients like poly(ethylene glycol) (PEG) can yield contradictory outcomes on protein stability.
- Platelet-derived growth factor-AA (PDGF-AA) is crucial for neural stem/progenitor cell (NSPC) survival and oligodendrocyte differentiation, key processes in central nervous system regeneration.
Purpose of the Study:
- To investigate the impact of low molecular weight PEG on the stability and bioactivity of encapsulated PDGF-AA within poly(lactide-co-glycolide) nanoparticles.
- To develop and validate an injectable nanoparticle/hydrogel drug delivery system for controlled release of bioactive PDGF-AA.
Main Methods:
- Encapsulation of PDGF-AA in poly(lactide-co-glycolide) nanoparticles, with and without co-encapsulated low molecular weight PEG.
- Assessment of PDGF-AA loading efficiency, release kinetics over 21 days, aggregation state via ELISA, and bioactivity through NSPC oligodendrocyte differentiation assays.
Main Results:
- Co-encapsulation of PEG increased PDGF-AA loading but significantly accelerated protein aggregation, leading to reduced bioactivity.
- PDGF-AA released from nanoparticles without PEG maintained its bioactivity, effectively inducing NSPC oligodendrocyte differentiation, comparable to fresh PDGF-AA controls.
- The study demonstrated controlled, sustained release of bioactive PDGF-AA from an injectable nanoparticle/hydrogel system.
Conclusions:
- Low molecular weight PEG has a detrimental effect on PDGF-AA stability and bioactivity during encapsulation in polymeric nanoparticles.
- The developed nanoparticle/hydrogel system enables controlled release of bioactive PDGF-AA, offering a promising strategy for central nervous system regeneration.
- This research provides critical insights into the role of excipients in protein encapsulation and highlights a novel approach for delivering differentiation factors.
More Related Videos
09:39Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
Published on: February 7, 2021
15:33Microwave-assisted Functionalization of Polyethylene glycol and On-resin Peptides for Use in Chain Polymerizations and Hydrogel Formation
Published on: October 29, 2013